Table 3

Survival rate of patients in OMT/LN group and non-OMT/LNgroup of different stages and histological subtypes

Groupn5-year Survival Rate (%) P value10-year Survival Rate (%) P value
Total 24598.9-97.5-
OMT/LN19096.80.34096.80.340
non-OMT/LN55100100
Stage
Stage I21698.4-96.2-
OMT/LN16798.40.43496.20.331
non-OMT/LN49100100
Stage II28100-100-
OMT/LN22100-100-
non-OMT/LN6100100
Histology
YST6094.5-94.5-
OMT/LN4894.50.46894.50.468
non-OMT/LN12100100
DSG74100-94.7-
OMT/LN56100-94.70.544
non-OMT/LN18100100
IMT111100-100-
OMT/LN86100-100-
non-OMT/LN25100100
  • DSG, dysgerminoma; IMT, immature teratoma; LN, lymphadenectomy; OMT, omentectomy; YST, yolk sac tumor.